Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension
Gangcheng ZHANG; Xiaoke SHANG; Xiaoxian DENG; Hongmei ZHOU.
Chinese Journal of Cardiology
; (12): 1001-1005, 2014.
ArtÃculo en Zh | WPRIM | ID: wpr-303789
Documentos relacionados
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension.
[Clinical characteristics of 195 Chinese patients with WHO Class I pulmonary hypertension].
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial.
Metabolomics in Pulmonary Hypertension-A Useful Tool to Provide Insights into the Dark Side of a Tricky Pathology.
Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
New Drugs and Therapies in Pulmonary Arterial Hypertension.
The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs.
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension.
[Primary Sjogren's syndrome associated pulmonary arterial hypertension: 20 new cases].